Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Immunohistochemical studies of transforming growth factor‐p (TGF‐P) and its receptors have been carried out on 16 glioma tissues and compared with 5 cases of gliosis. Significantly higher expressions of TGF‐βI, as well as type‐I and type‐II TGF‐β receptors (TβR‐I and TβR‐II, respectively), were observed in advanced‐malignant‐glioma tissues when compared with non‐tumorous gliosis. Immunoreactivities of TGF‐β and TβR‐I were localized in the cytoplasm of spindle‐shaped tumor cells surrounding proliferating vessels or around areas of necrosis. The advancing edge of the tumor clusters frequently stained positive. Similar expression patterns were found for TGF‐β2 and TGF‐β3, whereas only weak or no expression was found for endoglin. In low‐grade astrocytomas and in gliosis cases, the expression was moderate for TβR‐I and weak for TGF‐β and TβR‐II. In 3 examined human malignant glioma cell lines, clear immunostainings were detected for TGF‐β and its receptors. Ligand‐induced heteromeric complexes of the receptors were formed in these cell lines, but the amount of the receptors was less than that of mink lung epithelial cells, which are sensitive target cells for TGF‐β. TGF‐β I showed no growth‐inhibitory activity on any of these glioma cell lines. These results suggest that malignant gliomas produce TGF‐β and receptors, but are refractory to TGF‐β, implying dysregulation in the signalling pathway in the tumor cells. It is possible that the released TGF‐β acts on neighboring cells and affects stromal growth, angiogenesis, metastasis or immune surveillance in human glioma. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Cited by
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725
“The receptors for TGF- are also upregulated in GBM, especially as compared to nontumor glial tissue (Yamada et al., 1995).”
BackgroundTGF-β – an excellent servant but a bad master
Kubiczkova, L., Sedlarikova, L., Hajek, R., & Sevcikova, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-183 · Cited by 511
“Several studies describe mutations in TβRI and TβRII in adenomas and gliomas [148,149] as well as correlation between higher expression of TβRI and TβRII with more aggressive glioma cell lines and tumors [150,151].”
BackgroundGlioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β
Wick, W., Platten, M., & Weller, M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012209518843 · Cited by 271
Wesolowska, A., Kwiatkowska, A., Slomnicki, L., Dembinski, M., Master, A., Sliwa, M., Franciszkiewicz, K., Chouaib, S., & Kaminska, B. (2008) · Oncogene · doi:10.1038/sj.onc.1210683 · Cited by 258
Glioma infiltration and extracellular matrix: key players and modulators
Ferrer, V. P., Moura Neto, V., & Mentlein, R. (2018) · Glia · doi:10.1002/glia.23309 · Cited by 222
“Both TGFRI and TFGRII receptors are also overexpressed in gliomas (Yamada et al., 1995; Vega, Graner, & Sampson, 2008) In gliomas, TGF-b signaling has both tumor-suppressing and tumor-promoting functions, with the latter being more pronounced (Joseph, Balasubramaniyan, Walenkamp, & Kruyt, 2013).”
BackgroundInfluential
Metadata
- Authors
- Yamada, N., Kato, M., Yamashita, H., Nistér, M., Miyazono, K., Heldin, C., & Funa, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-08-09
- Volume
- 62
- Issue
- 4
- Pages
- 386-392
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2077372004
- Cited by
- 127
- References
- 1
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma. https://app.cochat.ai/papers/10.1002/ijc.2910620405
- The paper
- Yamada, N., Kato, M., Yamashita, H., Nistér, M., Miyazono, K., Heldin, C., & Funa, K. (1995). Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma. International Journal of Cancer. https://doi.org/10.1002/ijc.2910620405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.